Propanc Biopharma Stock Market Value
| PPCB Stock | USD 0.0003 0.0001 25.00% |
| Symbol | Propanc |
Propanc Biopharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Propanc Biopharma's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Propanc Biopharma.
| 10/23/2024 |
| 11/22/2024 |
If you would invest 0.00 in Propanc Biopharma on October 23, 2024 and sell it all today you would earn a total of 0.00 from holding Propanc Biopharma or generate 0.0% return on investment in Propanc Biopharma over 30 days. Propanc Biopharma is related to or competes with Rezolute, Tempest Therapeutics, Forte Biosciences, Dyadic International, DiaMedica Therapeutics, Silo Pharma, and Molecular Partners. Propanc Biopharma, Inc., a biopharmaceutical company, develops cancer treatments for patients with pancreatic, ovarian, ... More
Propanc Biopharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Propanc Biopharma's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Propanc Biopharma upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 26.43 | |||
| Information Ratio | 0.0146 | |||
| Maximum Drawdown | 58.33 | |||
| Value At Risk | (25.00) | |||
| Potential Upside | 33.33 |
Propanc Biopharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Propanc Biopharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Propanc Biopharma's standard deviation. In reality, there are many statistical measures that can use Propanc Biopharma historical prices to predict the future Propanc Biopharma's volatility.| Risk Adjusted Performance | 0.0262 | |||
| Jensen Alpha | 0.0387 | |||
| Total Risk Alpha | (1.64) | |||
| Sortino Ratio | 0.0083 | |||
| Treynor Ratio | 0.1133 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Propanc Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Propanc Biopharma Backtested Returns
Propanc Biopharma appears to be out of control, given 3 months investment horizon. Propanc Biopharma maintains Sharpe Ratio (i.e., Efficiency) of 0.0437, which implies the firm had a 0.0437% return per unit of risk over the last 3 months. By analyzing Propanc Biopharma's technical indicators, you can evaluate if the expected return of 0.66% is justified by implied risk. Please evaluate Propanc Biopharma's Coefficient Of Variation of 4564.65, risk adjusted performance of 0.0262, and Semi Deviation of 10.58 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Propanc Biopharma holds a performance score of 3. The company holds a Beta of 2.81, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Propanc Biopharma will likely underperform. Please check Propanc Biopharma's treynor ratio, expected short fall, day typical price, as well as the relationship between the potential upside and daily balance of power , to make a quick decision on whether Propanc Biopharma's historical price patterns will revert.
Auto-correlation | 0.47 |
Average predictability
Propanc Biopharma has average predictability. Overlapping area represents the amount of predictability between Propanc Biopharma time series from 23rd of October 2024 to 7th of November 2024 and 7th of November 2024 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Propanc Biopharma price movement. The serial correlation of 0.47 indicates that about 47.0% of current Propanc Biopharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.47 | |
| Spearman Rank Test | 0.07 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Propanc Biopharma lagged returns against current returns
Autocorrelation, which is Propanc Biopharma pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Propanc Biopharma's pink sheet expected returns. We can calculate the autocorrelation of Propanc Biopharma returns to help us make a trade decision. For example, suppose you find that Propanc Biopharma has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Propanc Biopharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Propanc Biopharma pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Propanc Biopharma pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Propanc Biopharma pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Propanc Biopharma Lagged Returns
When evaluating Propanc Biopharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Propanc Biopharma pink sheet have on its future price. Propanc Biopharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Propanc Biopharma autocorrelation shows the relationship between Propanc Biopharma pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Propanc Biopharma.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Propanc Pink Sheet
Propanc Biopharma financial ratios help investors to determine whether Propanc Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Propanc with respect to the benefits of owning Propanc Biopharma security.